|
1
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rich JN and Eyler CE: Cancer stem cells in
brain tumor biology. Cold Spring Harb Symp Quant Biol. 73:411–420.
2008. View Article : Google Scholar
|
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Balendiran GK, Schnutgen F, Scapin G,
Borchers T, Xhong N, Lim K, Godbout R, Spener F and Sacchettini JC:
Crystal structure and thermodynamic analysis of human brain fatty
acid-binding protein. J Biol Chem. 275:27045–27054. 2000.PubMed/NCBI
|
|
5
|
Liang Y, Bollen AW, Aldape KD and Gupta N:
Nuclear FABP7 immunoreactivity is preferentially expressed in
infiltrative glioma and is associated with poor prognosis in
EGFR-overexpressing glioblastoma. BMC Cancer. 6:972006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morihiro Y, Yasumoto Y, Vaidyan LK,
Sadahiro H, Uchida T, Inamura A, Sharifi K, Ideguchi M, Nomura S,
Tokuda N, et al: Fatty acid binding protein 7 as a marker of glioma
stem cells. Pathol Int. 63:546–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang Y, Diehn M, Watson N, Bollen AW,
Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown
PO, et al: Gene expression profiling reveals molecularly and
clinically distinct subtypes of glioblastoma multiforme. Proc Natl
Acad Sci USA. 102:5814–5819. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mita R, Beaulieu MJ, Field C and Godbout
R: Brain fatty acid-binding protein and omega-3/omega-6 fatty
acids: Mechanistic insight into malignant glioma cell migration. J
Biol Chem. 285:37005–37015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Rosa A, Pellegatta S, Rossi M, Tunici
P, Magnoni L, Speranza MC, Malusa F, Miragliotta V, Mori E,
Finocchiaro G, et al: A radial glia gene marker, fatty acid binding
protein 7 (FABP7), is involved in proliferation and invasion of
glioblastoma cells. PLoS One. 7:e521132012. View Article : Google Scholar
|
|
10
|
Berger J and Moller DE: The mechanisms of
action of PPARs. Annu Rev Med. 53:409–435. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arai Y, Funatsu N, Numayama-Tsuruta K,
Nomura T, Nakamura S and Osumi N: Role of Fabp7, a downstream gene
of Pax6, in the maintenance of neuroepithelial cells during early
embryonic development of the rat cortex. J Neurosci. 25:9752–9761.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu RZ, Monckton EA and Godbout R:
Regulation of the FABP7 gene by PAX6 in malignant glioma cells.
Biochem Biophys Res Commun. 422:482–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brun M, Coles JE, Monckton EA, Glubrecht
DD, Bisgrove D and Godbout R: Nuclear factor I regulates brain
fatty acid-binding protein and glial fibrillary acidic protein gene
expression in malignant glioma cell lines. J Mol Biol. 391:282–300.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sherr CJ: Principles of tumor suppression.
Cell. 116:235–246. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sue YM, Chung CP, Lin H, Chou Y, Jen CY,
Li HF, Chang CC and Juan SH: PPARdelta-mediated p21/p27 induction
via increased CReB-binding protein nuclear translocation in
beraprost-induced antiproliferation of murine aortic smooth muscle
cells. Am J Physiol Cell Physiol. 297:C321–C329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han DF, Zhang JX, Wei WJ, Tao T, Hu Q,
Wang YY, Wang XF, Liu N and You YP: Fenofibrate induces G0/G1 phase
arrest by modulating the PPARalpha/FoxO1/p27 kip pathway in human
glioblastoma cells. Tumour Biol. 36:3823–3829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang D, Wang G, Han D, Zhang Y, Xu J, Lu
J, Li S, Xie X, Liu L, Dong L, et al: Activation of PPAR-γ
ameliorates pulmonary arterial hypertension via inducing heme
oxygenase-1 and p21 (WAF1): An in vivo study in rats. Life Sci.
98:39–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bonofiglio D, Qi H, Gabriele S, Catalano
S, Aquila S, Belmonte M and Andò S: Peroxisome
proliferator-activated receptor gamma inhibits follicular and
anaplastic thyroid carcinoma cells growth by upregulating
p21Cip1/WAF1 gene in a Sp1-dependent manner. Endocr Relat Cancer.
15:545–557. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hasan AU, Ohmori K, Hashimoto T, Kamitori
K, Hirata Y, Ishihara Y, Okamoto N, Noma T, Kosaka H, Tokuda M, et
al: Pioglitazone promotes preadipocyte proliferation by
down-regulating p16(Ink4a). Biochem Biophys Res Commun.
411:375–380. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gizard F, Nomiyama T, Zhao Y, Findeisen
HM, Heywood EB, Jones KL, Staels B and Bruemmer D: The
PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell
proliferation by repressing cell cycle-dependent telomerase
activation. Circ Res. 103:1155–1163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gizard F and Staels B: The
fibrate-activated PPARalpha/p16INK4A pathway inhibits vascular
smooth muscle cell proliferation and vascular occlusion. Med Sci
(Paris). 22:351–353. 2006.In French. View Article : Google Scholar
|
|
22
|
Duparc RH, Abdouh M, David J, Lépine M,
Tétreault N and Bernier G: Pax6 controls the proliferation rate of
neuroepithelial progenitors from the mouse optic vesicle. Dev Biol.
301:374–387. 2007. View Article : Google Scholar
|
|
23
|
Farhy C, Elgart M, Shapira Z, Oron-Karni
V, Yaron O, Menuchin Y, Rechavi G and Ashery-Padan R: Pax6 is
required for normal cell-cycle exit and the differentiation
kinetics of retinal progenitor cells. PLoS One. 8:e764892013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng B, Wang Y and Li B: Suppression of
PAX6 promotes cell proliferation and inhibits apoptosis in human
retinoblastoma cells. Int J Mol Med. 34:399–408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ouellet S, Vigneault F, Lessard M, Leclerc
S, Drouin R and Guérin SL: Transcriptional regulation of the
cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in
proliferating human cells. Nucleic Acids Res. 34:6472–6487. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee JS, Xiao J, Patel P, Schade J, Wang J,
Deneen B, Erdreichepstein A and Song HR: A novel tumor-promoting
role for nuclear factor IA in glioblastomas is mediated through
negative regulation of p53, p21 and PAI1. Neuro Oncol. 16:191–203.
2014. View Article : Google Scholar
|
|
27
|
Barth RF and Kaur B: Rat brain tumor
models in experimental neurooncology: The C6, 9L, T9, RG2, F98,
BT4C, RT-2 and CNS-1 gliomas. J Neurooncol. 94:299–312. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leary S, Underwood W, Anthony R, Cartner
S, Corey D, Grandin T, Greenacre C, Gwaltney-Brant S, McCrackin MA,
Meyer R, et al: AVMA Guidelines for the euthanasia of Animals.
2013. https://www.avma.org/KB/Policies/Documents/euthanasia.pdf.
|
|
29
|
Ishii N, Maier D, Merlo A, Tada M,
Sawamura Y, Diserens AC and Van Meir EG: Frequent co-alterations of
TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human
glioma cell lines. Brain Pathol. 9:469–479. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sharifi K, Morihiro Y, Maekawa M, Yasumoto
Y, Hoshi H, Adachi Y, Sawada T, Tokuda N, Kondo H, Yoshikawa T, et
al: FABP7 expression in normal and stab-injured brain cortex and
its role in astrocyte proliferation. Histochem Cell Biol.
136:501–513. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kipp M, Clarner T, Gingele S, Pott F, Amor
S, van der Valk P and Beyer C: Brain lipid binding protein (FABP7)
as modulator of astrocyte function. Physiol Res. 60(Suppl 1):
S49–S60. 2011.PubMed/NCBI
|
|
32
|
Kipp M, Gingele S, Pott F, Clarner T, van
der Valk P, Denecke B, Gan L, Siffrin V, Zipp F, Dreher W, et al:
BLBP-expression in astrocytes during experimental demyelination and
in human multiple sclerosis lesions. Brain Behav Immun.
25:1554–1568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li H, Jin G, Qin J, Yang W, Tian M, Tan X,
Zhang X, Shi J and Zou L: Identification of neonatal rat
hippocampal radial glia cells in vitro. Neurosci Lett. 490:209–214.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: Primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14(Suppl 5): v1–v49. 2012. View Article : Google Scholar :
|
|
35
|
Banan R and Hartmann C: The new WHO 2016
classification of brain tumors-what neurosurgeons need to know.
Acta Neurochir (Wien). 159:403–418. 2017. View Article : Google Scholar
|
|
36
|
Kaloshi G, Mokhtari K, Carpentier C,
Taillibert S, Lejeune J, Marie Y, Delattre JY, Godbout R and Sanson
M: FABP7 expression in glioblastomas: Relation to prognosis,
invasion and EGFR status. J Neurooncol. 84:245–248. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mita R, Coles JE, Glubrecht DD, Sung R,
Sun X and Godbout R: B-FABP-expressing radial glial cells: The
malignant glioma cell of origin? Neoplasia. 9:734–744. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo P, Hu B, Gu W, Xu L, Wang D, Huang HJ,
Cavenee WK and Cheng SY: Platelet-derived growth factor-B enhances
glioma angiogenesis by stimulating vascular endothelial growth
factor expression in tumor endothelia and by promoting pericyte
recruitment. Am J Pathol. 162:1083–1093. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Heimberger AB, Suki D, Yang D, Shi W and
Aldape K: The natural history of EGFR and EGFRvIII in glioblastoma
patients. J Transl Med. 3:382005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Morford LA, Boghaert ER, Brooks WH and
Roszman TL: Insulin-like growth factors (IGF) enhance
three-dimensional (3D) growth of human glioblastomas. Cancer Lett.
115:81–90. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sibenaller ZA, Etame AB, Ali MM, Barua M,
Braun TA, Casavant TL and Ryken TC: Genetic characterization of
commonly used glioma cell lines in the rat animal model system.
Neurosurg Focus. 19:E12005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Diotel N, Vaillant C, Kah O and Pellegrini
E: Mapping of brain lipid binding protein (Blbp) in the brain of
adult zebrafish, co-expression with aromatase B and links with
proliferation. Gene expr Patterns. 20:42–54. 2016. View Article : Google Scholar
|
|
43
|
Ponnusamy M, Li PF and Wang K:
Understanding cardiomyocyte proliferation: An insight into cell
cycle activity. Cell Mol Life Sci. 74:1019–1034. 2017. View Article : Google Scholar
|
|
44
|
Piatti S: Cell cycle regulation of S phase
entry in Saccharomyces cerevisiae. Prog Cell Cycle Res. 3:143–156.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Krek W: Proteolysis and the G1-S
transition: The SCF connection. Curr Opin Genet Dev. 8:36–42. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hendler A, Medina EM, Buchler NE, de Bruin
RAM and Aharoni A: The evolution of a G1/S transcriptional network
in yeasts. Curr Genet. Jul 25–2017.epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Singh SK, Banerjee S, Acosta EP, Lillard
JW and Singh R: Resveratrol induces cell cycle arrest and apoptosis
with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and
p27KIP1 pathway. Oncotarget. 8:17216–17228. 2017.PubMed/NCBI
|
|
48
|
Prieur A, Besnard E, Babled A and Lemaitre
JM: p53 and p16(INK4A) independent induction of senescence by
chromatin-dependent alteration of S-phase progression. Nat Commun.
2:4732011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chu IM, Hengst L and Slingerland JM: The
Cdk inhibitor p27 in human cancer: Prognostic potential and
relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gartel AL and Radhakrishnan SK: Lost in
transcription: p21 repression, mechanisms, and consequences. Cancer
Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rayess H, Wang MB and Srivatsan ES:
Cellular senescence and tumor suppressor gene p16. Int J Cancer.
130:1715–1725. 2012. View Article : Google Scholar :
|
|
52
|
Benadiba M, Dos Santos RR, Silva DO and
Colquhoun A: Inhibition of C6 rat glioma proliferation by
[Ru2Cl(Ibp)4] depends on changes in p21, p27, Bax/Bcl2 ratio and
mitochondrial membrane potential. J Inorg Biochem. 104:928–935.
2010. View Article : Google Scholar : PubMed/NCBI
|
